HEALTH CANADA APPROVES LILLY'S MOUNJARO® (TIRZEPATIDE) TO REDUCE CARDIOVASCULAR RISK IN ADULTS WITH TYPE 2 DIABETES

Reuters · 4d ago

Please log in to view news